Objective: Alzheimer disease (AD) is a chronic neurodegenerative disorder that affects
millions of individuals worldwide. Symptoms include memory dysfunction and deficits in …

Background: Olfactory deficits are prevalent in patients with Alzheimer's disease (AD) and
mild cognitive impairment (MCI). These symptoms precede clinical onset of cognitive and …

Introduction Pathological abnormalities first appear in the medial temporal regions including
entorhinal cortex and parahippocampus in patients with Alzheimer's disease. Previous …

Objectives The underlying mechanism of the association between olfactory impairment and
dementia may be explained by neurodegenerative changes detected on magnetic …

There is increasing histopathological evidence that the olfactory bulb and tract (OBT) is a
primary focus of neurodegenerative changes in Alzheimer's disease (AD). Correspondingly …

Even in early stages, Alzheimer's disease (AD) is associated with olfactory deficit. We
assess the association of volumetric differences in subcortical deep gray matter (DGM) …

Background: Olfactory deficits are present in early Alzheimer's disease (AD) and mild
cognitively impaired (MCI) patients. However, whether these deficits are due to dysfunction …

Olfactory identification deficit (OID) has been associated with both aging and Alzheimer's
disease (AD). In the context of an amnestic disorders, OID predicts conversion to AD …

Alzheimer's disease (AD) is a prevalent form of dementia that affects an estimated 32 million
individuals globally. Identifying early indicators is vital for screening at-risk populations and …

The very high sensitivity and specificity of odor identification tasks in discriminating between
Alzheimer's patients and normals suggests that they reflect the presence of underlying …